Compounds > 1,3,4-oxadiazole
Page last updated: 2024-08-26

1,3,4-oxadiazole and Koch's Disease

1,3,4-oxadiazole has been researched along with Koch's Disease in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Huszár, S; Janoušek, J; Korduláková, J; Krátký, M; Madacki, J; Mikušová, K; Stolaříková, J; Švarcová, M; Trejtnar, F; Vinšová, J; Vosátka, R1
Azger Dusthackeer, VN; Chopra, S; Krishna, EV; Krishna, VS; Mahizhaveni, B; Makane, VB; Misra, S; Rode, HB; Shukla, M; Sriram, D1
Bhatt, K; Desai, NC; Jha, PC; Khedkar, VM; Nawale, L; Sarkar, D; Somani, H; Trivedi, A1
Joshi, RA; Joshi, RR; Likhite, AP; Nawale, L; Rode, ND; Sarkar, D; Sonawane, AD1
Nagarapu, L; Nanubolu, JB; Perumal, Y; Sajja, Y; Sriram, D; Vanguru, S; Vulupala, HR1

Other Studies

5 other study(ies) available for 1,3,4-oxadiazole and Koch's Disease

ArticleYear
New lipophilic isoniazid derivatives and their 1,3,4-oxadiazole analogues: Synthesis, antimycobacterial activity and investigation of their mechanism of action.
    European journal of medicinal chemistry, 2018, May-10, Volume: 151

    Topics: Antitubercular Agents; Drug Resistance, Bacterial; Hep G2 Cells; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxadiazoles; Tuberculosis

2018
Novel 1,3,4-oxadiazoles as antitubercular agents with limited activity against drug-resistant tuberculosis.
    Future medicinal chemistry, 2019, Volume: 11, Issue:6

    Topics: Antitubercular Agents; Cell Line; Humans; Models, Molecular; Mycobacterium tuberculosis; Oxadiazoles; Tuberculosis; Tuberculosis, Multidrug-Resistant

2019
Synthesis, biological evaluation and molecular docking study of some novel indole and pyridine based 1,3,4-oxadiazole derivatives as potential antitubercular agents.
    Bioorganic & medicinal chemistry letters, 2016, Apr-01, Volume: 26, Issue:7

    Topics: Animals; Antitubercular Agents; Cell Line; Humans; Indoles; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium bovis; Mycobacterium tuberculosis; Oxadiazoles; Pyridines; Structure-Activity Relationship; Tuberculosis

2016
Synthesis and biological evaluation of 1,2,4-triazole-3-thione and 1,3,4-oxadiazole-2-thione as antimycobacterial agents.
    Chemical biology & drug design, 2017, Volume: 90, Issue:2

    Topics: Antitubercular Agents; Cell Line, Tumor; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxadiazoles; Thiones; Triazoles; Tuberculosis

2017
Design, synthesis, and in vitro antituberculosis activity of benzo[6,7]cyclohepta[1,2-b]pyridine-1,3,4-oxadiazole derivatives.
    Chemical biology & drug design, 2017, Volume: 90, Issue:4

    Topics: Antitubercular Agents; Drug Design; Humans; Microbial Sensitivity Tests; Models, Molecular; Mycobacterium tuberculosis; Oxadiazoles; Pyridines; Structure-Activity Relationship; Tuberculosis

2017